Ihsan Ates

Dr. Ihsan Ates


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Hepatobiliary & Pancreatic Diseases International
Verified
Journal Article
Closed access
MKMustafa Kaplan
Mustafa Kaplan
IAIhsan Ates
Ihsan Ates
MAMuhammed Yener Akpinar
Muhammed Yener Akpinar
MYMahmut Yuksel
Mahmut Yuksel
UKUfuk Baris Kuzu
Ufuk Baris Kuzu
EKErtugrul Kayacetin
Ertugrul Kayacetin

5 June 2020 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
EKE. Asfuroglu Kalkan
E. Asfuroglu Kalkan
IAIhsan Ates
Ihsan Ates

7 November 2015 in Endocrine
Verified
Journal Article
Closed access
PDF file
IAIhsan Ates
Ihsan Ates
MKMustafa Kaplan
Mustafa Kaplan
MYMahmut Yuksel
Mahmut Yuksel
DMDuygu Mese
Duygu Mese
MAMurat Alisik
Murat Alisik
SGSerdar Guler
Serdar Guler

1 December 2015 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
IAIhsan Ates
Ihsan Ates
FYFatma Meric Yilmaz
Fatma Meric Yilmaz
MAMustafa Altay
Mustafa Altay
NYNisbet Yilmaz
Nisbet Yilmaz
DBDilek Berker
Dilek Berker
SGSerdar Güler
Serdar Güler
Objective: We have aimed to study the relation between Hashimoto's thyroiditis (HT) and thyroid autoantibodies and oxidative stress parameters in euthyroid, subclinical and overt hypothyroid stages.Design and methods: A total of 124 patients were included in the study; 93 of whom were newly diagnosed with HT (31 patients in each of the euthyroid, subclinical hypothyroid and overt hypothyroid subgroups), aged over 18 and had not received any prior treatment and 31 of whom were healthy volunteers.Results: Total oxidant status (TOS) and oxidative stress index (OSI) levels were higher, and total antioxidant status (TAS) and total thiol and arylesterase levels were lower in the overt hypothyroid group compared to other groups. TOS and OSI levels increased, and TAS levels decreased significantly in each phase from euthyroid, subclinical hypothyroid, to overt hypothyroid subgroups among HT patients. There was a negative correlation between TAS, log (paraoxonase1) and paraoxonase1/HDL and anti-thyroid peroxidase and a negative correlation between anti-thyroglobulin and total thiol. It was also determined that overt hypothroidism was an individual predictor that effects all of the oxidative stress parameters, but not total thiol, levels.Conclusion: Our results suggest that oxidative stress increases continuously during the development of subclinical hypothyroidism and overt hypothyroidism in patients with HT. To determine whether this is a cause or result, randomized, controlled trials that study the effect of antioxidant treatment on the development of overt hypothyroidism and its consequences, e.g., increase in total cholesterol levels, may be performed in euthyroid and/or subclinical hypothyroid patients with HT.

1 November 2015 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
IAIhsan Ates
Ihsan Ates
MKMustafa Kaplan
Mustafa Kaplan
BIBayram Inan
Bayram Inan
MAMurat Alisik
Murat Alisik
OEOzcan Erel
Ozcan Erel
SGSerdar Guler
Serdar Guler

1 February 2016 in Journal of the American Society of Hypertension
Verified
Journal Article
Closed access
IAIhsan Ates
Ihsan Ates
NONihal Ozkayar
Nihal Ozkayar
BIBayram Inan
Bayram Inan
FYFatma Meric Yilmaz
Fatma Meric Yilmaz
CTCanan Topcuoglu
Canan Topcuoglu
NYNisbet Yilmaz
Nisbet Yilmaz